𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LRRK2andGBAmutations differentially affect the initial presentation of Parkinson disease

✍ Scribed by Z. Gan-Or; A. Bar-Shira; A. Mirelman; T. Gurevich; M. Kedmi; N. Giladi; A. Orr-Urtreger

Publisher
Springer
Year
2009
Tongue
English
Weight
111 KB
Volume
11
Category
Article
ISSN
1364-6745

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The biology and pathology of the familia
The biology and pathology of the familial Parkinson's disease protein LRRK2
✍ William Dauer; Cherry Cheng-Ying Ho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract Parkinson's disease (PD) is typically a sporadic illness, but the past decade has witnessed the identification of mutations responsible for multiple familial forms of the disease. The proposed functions of some of these genes (e.g., E3 ubiquitin ligase, redox‐dependent chaperone) have l

Pathogenicity of the Lrrk2 R1514Q substi
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease
✍ Mathias Toft; Ignacio F. Mata; Owen A. Ross; Jennifer Kachergus; Mary M. Hulihan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract An increasing number of nonsynonymous __LRRK2__ variants are being reported as putative pathogenic mutations. We identified one large kindred harboring the Lrrk2 R1514Q substitution; however, the variant did not segregate fully with disease. Combined analyses of three case–control serie

Neuropathology of Parkinson's disease as
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
✍ Maria Teresa Giordana; Carla D'Agostino; Giovanni Albani; Alessandro Mauro; Ales 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract __Leucine‐Rich Repeat Kinase 2__ (__LRRK2__) gene mutations are the most common known cause of Parkinson's disease (PD), but neuropathological studies are available on very few patients with __LRRK2__ mutation. The reported findings range from Lewy body–positive pathology to different p

Neuropathology of Parkinson's disease wi
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2
✍ José-Félix Martí-Massó; Javier Ruiz-Martínez; Maria J. Bolaño; Irune Ruiz; Ana G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Abstract We report the neuropathological findings in a patient with Parkinson's disease (PD) associated with Basque R1441G‐__LRRK2__/dardarin mutation. The patient was a man with disease onset at 68 years of age, with unilateral rest tremor; the Parkinsonism was well controlled with medication f

Leucine-rich repeat kinase 2 (LRRK2): A
Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
✍ Payal N. Gandhi; Shu G. Chen; Amy L. Wilson-Delfosse 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years. Mutations in the gene encoding leucine‐rich repeat kinase‐2 (__LRRK2__) have recently been linked to autosomal dominant, late‐onset PD that is cl

Genetic LRRK2 models of Parkinson's dise
Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications
✍ Zhenyu Yue; M. Lenard Lachenmayer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

## Abstract Dominantly inherited mutations in leucine‐rich repeat kinase 2 are the most common cause of familial Parkinson's disease. Understanding leucine‐rich repeat kinase 2 biology and pathophysiology is central to the elucidation of Parkinson's disease etiology and development of disease inter